US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

266.00

-13.0200-4.67%

Pre-market: 269.023.02+1.14%04:15 EDT

Volume:290.13K

Turnover:77.49M

Market Cap:498.61M

PE:- -

High:274.71

Open:269.37

Low:260.01

Close:279.02

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.94

T/O Rate:15.48%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

What AMN Healthcare Services (AMN)'s New Nursing Leadership Council Role Means For Shareholders

Simply Wall St.

Aster DM Quality Care to Merge Hospitality Subsidiaries for Structural, Operational Gains

Neurocrine Biosciences (NBIX) Cleared An FDA Milestone, Is It Trading At A Discount?

Simply Wall St.

National Healthcare Insider Makes Major Move in High-Value Stock Sale

Insider Move: Sensus Healthcare Director Quietly Boosts His Stake in the Company

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition

Takeda receives FDA approval of NDA for Mimrylo

FDA Authorizes Juul to Sell New E-Cigarette

3 Penny Stocks With Real Revenue And Solid Balance Sheets

Simply Wall St.

Health Care Down, but not by Much, on Rotation Out of Rate-Sensitive Areas - Health Care Roundup

Why Sonic Healthcare (ASX:SHL) Is Back In The Spotlight

Simply Wall St.

Juul Labs Gets FDA Authorization to Sell New E-Cigarette

Sector Update: Healthcare

MT Newswires Live

Ramsay Health Care (ASX:RHC): Is Profitability Rebound Recasting Its Core Risk-Reward Profile?

Simply Wall St.

FDA authorizes marketing of JUUL2 E-cigarette system products

Wall Street Analysts Are Bullish on Top Healthcare Picks

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Worldwide Healthcare Trust boosts treasury stock with latest share buyback

ISEC Healthcare’s Seremban Eye Centre Begins Operations After Securing License

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/LABU/news?page=20"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":266,"timestamp":1789070400000,"preClose":279.02,"halted":0,"volume":290130,"hourTrading":{"tag":"盘前","latestPrice":269.02,"preClose":266,"latestTime":"04:15 EDT","volume":28,"amount":7514.4944,"timestamp":1789114501020,"change":3.02,"changeRate":0.011353,"amplitude":0.009628},"delay":0,"changeRate":-0.046663321625689855,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Pre-Mkt","change":-13.02,"latestTime":"09-11 04:22:38 EDT","open":269.37,"high":274.705,"low":260.01,"amount":77488111.8858,"amplitude":0.052666,"askPrice":270.8,"askSize":400,"bidPrice":266.8,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":266,"sharesOutstanding":3074486,"nav":278.651,"aum":522328218.83,"dividendRate":0.003776,"bidAskSpread":0.002964,"preHourTrading":{"tag":"盘前","latestPrice":269.02,"preClose":266,"latestTime":"04:15 EDT","volume":28,"amount":7514.4944,"timestamp":1789114501020,"change":3.02,"changeRate":0.011353,"amplitude":0.009628},"postHourTrading":{"tag":"盘后","latestPrice":264.12,"preClose":266,"latestTime":"19:53 EDT","volume":1904,"amount":504475.6573,"timestamp":1789084425326,"change":-1.88,"changeRate":-0.007068,"amplitude":0.00782},"volumeRatio":0.9443493312965978,"impliedVol":0.9105,"impliedVolPercentile":0.504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9443493312965978,"shares":1874486,"dividePrice":1.0045,"high":274.705,"amplitude":0.052666,"preClose":279.02,"low":260.01,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":266,"committee":-0.333333,"eps":0,"divideRate":0.003776,"volume":290130,"delay":0,"ttmEps":0,"open":269.37,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":311.81,"twentyDayClose":286.75,"sixtyDayClose":188.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:20,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663017727","title":"What AMN Healthcare Services (AMN)'s New Nursing Leadership Council Role Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017727","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017727?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:20","pubTimestamp":1788013257,"startTime":"0","endTime":"0","summary":"AMN Healthcare Services recently joined the AONL Foundation Corporate Advisory Council, where it will be represented by Chief Nursing Executive Dr. Angelo Venditti and Head of Strategic Enterprise & Channel Partnerships Steven Endsley to support research, innovation and education in nursing leadership nationwide.\nThis council role gives AMN a platform to shape workforce innovation and nursing leadership priorities, aligning its workforce-planning and analytics capabilities with national...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/what-amn-healthcare-services-amns-new-nursing-leadership-cou","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-amn/amn-healthcare-services/news/what-amn-healthcare-services-amns-new-nursing-leadership-cou","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AMN.AU","BK4585","AMN","XBI","BK4196","BK4588","LABU","BK7095","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017625","title":"Aster DM Quality Care to Merge Hospitality Subsidiaries for Structural, Operational Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017625?lang=en_us&edition=fundamental","pubTime":"2026-08-29 21:12","pubTimestamp":1788009157,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ). Aster DM Quality Care Limited has announced that the boards of its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-to-merge-hospitality-subsidiaries-for-structural-operational-gains?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-to-merge-hospitality-subsidiaries-for-structural-operational-gains?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","BK4588","BK4581","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663017369","title":"Neurocrine Biosciences (NBIX) Cleared An FDA Milestone, Is It Trading At A Discount?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663017369","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663017369?lang=en_us&edition=fundamental","pubTime":"2026-08-29 17:19","pubTimestamp":1787995165,"startTime":"0","endTime":"0","summary":"FDA milestone puts Neurocrine Biosciences in focus\nThe FDA’s acceptance of Neurocrine Biosciences (NBIX) Investigational New Drug application for NBI-1117567 clears the way for a Phase 2 trial in Alzheimer’s cognition and triggers a US$10 million payment to partner Nxera Pharma.\nDespite the FDA milestone, Neurocrine Biosciences’ recent share price momentum has cooled, with the 30 day share price return down 14.79%, even as the year to date share price return is up 9.57% and the 5 year total...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-cleared-an-fda-milestone-is-it-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/neurocrine-biosciences-nbix-cleared-an-fda-milestone-is-it-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","LU0154245673.USD","LU0320765992.SGD","LU2065171402.SGD","LU2065171311.SGD","BK4588","NBIX","LU0823416689.USD","LU2065170008.USD","BK4139","LU0154245756.USD","CDIG","LU0109394709.USD","LU0889565916.HKD","LU2065169927.USD","LU2324357040.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011983","title":"National Healthcare Insider Makes Major Move in High-Value Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011983","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011983?lang=en_us&edition=fundamental","pubTime":"2026-08-29 10:10","pubTimestamp":1787969445,"startTime":"0","endTime":"0","summary":"New insider activity at National Healthcare ( ($NHC) ) has taken place on August 28, 2026. Director David R. Gifford has recently sold 1,779 shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/national-healthcare-insider-makes-major-move-in-high-value-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/national-healthcare-insider-makes-major-move-in-high-value-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XBI","XLV","LABU","BK4185","BK4585","BK4581","NHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663011614","title":"Insider Move: Sensus Healthcare Director Quietly Boosts His Stake in the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2663011614","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663011614?lang=en_us&edition=fundamental","pubTime":"2026-08-29 10:10","pubTimestamp":1787969423,"startTime":"0","endTime":"0","summary":"New insider activity at Sensus Healthcare ( ($SRTS) ) has taken place on August 28, 2026. Director Eric Sachetta has increased his stake in Sensus ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-sensus-healthcare-director-quietly-boosts-his-stake-in-the-company-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-sensus-healthcare-director-quietly-boosts-his-stake-in-the-company-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SRTS","BK4588","BK4585","XBI","XLV","BK4581","BK4082","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","LABU","IEIH","MEDI","BK4585","IDNA","BK4588","GNMX","LFSC","MRNX","TECB","IBB","PSCH","BMED","PINK","TBXU","RSPH","MRNY","GDOC","NVIB","FRTY","IYH","SYNB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016729","title":"Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016729","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016729?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:02","pubTimestamp":1787958120,"startTime":"0","endTime":"0","summary":"Takeda's treatment for erythrocytosis in adults with polycythemia vera, a form of blood cancer, received approval from the Food and Drug Administration.The company said Friday that the FDA approved its new drug application for Mimrylo, also known as rusfertide. The drug treats adults with erythrocytosis who have PV, a condition involving an abnormally high concentration of red blood cells.\"The approval of Mimrylo underscores the strength of Takeda's late-stage pipeline and our focus on developing genuinely differentiated therapies for patients who are urgently waiting for new options,\" Chief Executive Julie Kim said.The development does not impact Takeda's guidance for the current fiscal year, the company said.The agency's approval was based on data from the company's Phase 3 trial of the treatment. An open-label extension of that trial is continuing, and the company said it is engaging with international regulators about the drug.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","BMED","SYNB","GDOC","FRTY","RSPH","PINK","BBP","BK4007","TBXU","XLVX","NVIB","GNMX","PSCH","TAK","TECB","IBB","LFSC","LABU","IDNA","BK4588","IYH","IEIH","MRNX","MRNY","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006015","title":"FDA Authorizes Juul to Sell New E-Cigarette","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006015","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663006015?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:47","pubTimestamp":1787953620,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration gave Juul Labs the go-ahead to sell a new version of its e-cigarette and tobacco- and menthol-flavored pods, marking another win for the company after it got clearance","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663192110","title":"3 Penny Stocks With Real Revenue And Solid Balance Sheets","url":"https://stock-news.laohu8.com/highlight/detail?id=2663192110","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663192110?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:29","pubTimestamp":1787952565,"startTime":"0","endTime":"0","summary":"Global inflation readings in Europe are keeping interest rate expectations elevated, which keeps borrowing costs in focus for smaller companies. That is where the Financially Fit Penny Stocks screener becomes interesting. It filters for low priced stocks that still show solid financial health, so investors are not just chasing cheap tickers. This article highlights three stocks from the screener that may be worth considering for your watchlist.\nThe three stocks highlighted below are just a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/3-penny-stocks-with-real-revenue-and-solid-balance-sheets","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/3-penny-stocks-with-real-revenue-and-solid-balance-sheets","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7506","XBI","BK4588","ALK.AU","LABU","BK7067","SIG.AU","BK4581","BK4585","XLV","BK7104","BK7508","BK7103","MSB.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015241","title":"Health Care Down, but not by Much, on Rotation Out of Rate-Sensitive Areas - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015241","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015241?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:22","pubTimestamp":1787952120,"startTime":"0","endTime":"0","summary":"Health-care companies fell, but not by as much as the broad market, as traders rotated into sectors less sensitive to interest-rate movements.BioNTech shares slid after the biotech firm scrapped a clinical trial for its mRNA cancer vaccine, marking the second setback this year.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","NVIB","BK4585","LABU","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663301924","title":"Why Sonic Healthcare (ASX:SHL) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2663301924","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663301924?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:26","pubTimestamp":1787948766,"startTime":"0","endTime":"0","summary":"Why Sonic Healthcare’s latest earnings and dividend matter now\nSonic Healthcare (ASX:SHL) has drawn fresh attention after releasing full year 2026 results, confirming higher revenue and net income than a year earlier, alongside a declared dividend for the June half.\nSonic Healthcare’s share price has softened in the short term, with a 7 day share price return of 4.93% and a 30 day share price return of 11.8% down to A$20.04. The 1 year total shareholder return has declined 12.74%, pointing to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-shl/sonic-healthcare-shares/news/why-sonic-healthcare-asxshl-is-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-shl/sonic-healthcare-shares/news/why-sonic-healthcare-asxshl-is-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","XBI","SHL.AU","VIG","XLV","BK7124","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663139770","title":"Juul Labs Gets FDA Authorization to Sell New E-Cigarette","url":"https://stock-news.laohu8.com/highlight/detail?id=2663139770","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663139770?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:00","pubTimestamp":1787947200,"startTime":"0","endTime":"0","summary":"Juul Labs got the go-ahead from the Food and Drug Administration to sell a new version of its e-cigarette and tobacco- and menthol-flavored pods.The privately held vapor company said its updated vapin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Juul Labs Gets FDA Authorization to Sell New E-Cigarette","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013365","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013365","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013365?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:33","pubTimestamp":1787945609,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each shedding 0.4%.The iShares Biotechnology ETF  dropped 2.7%.In corporate news, 10x Genomics  said a Delaware federal jury awarded the company more than $4.8 million after finding that three patents held through its Scale Biosciences unit were infringed by Parse Biosciences, a subsidiary of Qiagen . 10x Genomics shares were down 5.2%, and Qiagen was shedding 1.3%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861558580.USD","LU1923622614.USD","TXG","BK4137","XLV","LU2125909593.SGD","QGEN","LU0963586101.USD","BK4588","XBI","BK4581","LU2433249047.HKD","BK4121","LU0029874061.USD","IBB","BK4585","LU0128526141.USD","LU1861559042.SGD","HCSG","ARKG","LABU","LU2125909247.SGD","FMED","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015531","title":"Ramsay Health Care (ASX:RHC): Is Profitability Rebound Recasting Its Core Risk-Reward Profile?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015531","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015531?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:22","pubTimestamp":1787944955,"startTime":"0","endTime":"0","summary":"Ramsay Health Care Limited recently reported full-year results to 30 June 2026, with sales rising to A$18.58 billion, revenue to A$18.71 billion, and net income increasing to A$329.2 million, lifting earnings per share from continuing operations to around A$1.36.\nThe results highlight how efficiency measures and cost management, alongside EBIT growth in all regions and positive net cash flow, have reshaped Ramsay’s profitability profile over the past year.\nWe’ll now explore how this rebound...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-rhc/ramsay-health-care-shares/news/ramsay-health-care-asxrhc-is-profitability-rebound-recasting","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-rhc/ramsay-health-care-shares/news/ramsay-health-care-asxrhc-is-profitability-rebound-recasting","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","DECU","AGIX","XLV","GXDW","BK4585","CHAT","LABU","RGLO","VTHR","PMDE","RHC.AU","QTOC","JOYT","BK7113","VOTE","XBI","BK4588","AIPO","VGFPF","ARTY","FEBU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018401","title":"FDA authorizes marketing of JUUL2 E-cigarette system products","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018401","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018401?lang=en_us&edition=fundamental","pubTime":"2026-08-29 02:20","pubTimestamp":1787941219,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration authorized the marketing of three new e-cigarette products through the premarket tobacco product application ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-authorizes-marketing-of-juul2-e-cigarette-system-products-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-authorizes-marketing-of-juul2-e-cigarette-system-products-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663881018","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2663881018","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663881018?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:30","pubTimestamp":1787938215,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK) and Ibio (IBIO) with bullish sen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-317?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-317?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBIO","BK4568","HCSG","BK4137","XBI","CYTK","LU0128526141.USD","BK4139","LABU","LU0029874061.USD","BK4588","BK4581","BK4505","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1037948541.HKD","BK4566","LU1934455863.HKD","IE00B19Z3B42.SGD","LU1057294990.SGD","IE00B19Z3581.USD","IBB","GILD","LU1778281490.HKD","LU1037948897.HKD","TBXU","BK4139","SG9999015986.USD","BBH","LABU","LU1066053197.SGD","BK4578","BMED","IE00BKVL7J92.USD","TMED","LU0859254822.USD","BK4585","LU0122379950.USD","LU2357627491.SGD","LU0823416689.USD","LU1585245621.USD","LU2112291526.USD","LU0320765992.SGD","LU0965509010.AUD","SG9999015978.USD","BIB","IE0002270589.USD","SG9999015945.SGD","IE00BSNM7G36.USD","LU0889565916.HKD","BK4588","LU1571399168.USD","LU0114720955.EUR","LU0882574055.USD","IE00B3T34201.USD","LU1934455194.USD","LU1066051498.USD","LU0109394709.USD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU1934455277.USD","BK4532","MEDI","IBBQ","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663090461","title":"Worldwide Healthcare Trust boosts treasury stock with latest share buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2663090461","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663090461?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:13","pubTimestamp":1787937181,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) just unveiled an announcement. Worldwide Healthcare Trust PLC, a London-listed investment trust sp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-latest-share-buyback-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-latest-share-buyback-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US2Y.BOND","BRKU","ACKY","BRKC","BK4581","US30Y.BOND","US5Y.BOND","BRKD","HCSG","ACTV","US3Y.BOND","TMF","BK4588","US12M.BOND","LABU","XBI","TLT","XLV","BRKL","US6M.BOND","LU0029874061.USD","BK4585","BK4137","BRKW","LU0128526141.USD","US10Y.BOND","TLTW","US7Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662409231","title":"ISEC Healthcare’s Seremban Eye Centre Begins Operations After Securing License","url":"https://stock-news.laohu8.com/highlight/detail?id=2662409231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662409231?lang=en_us&edition=fundamental","pubTime":"2026-08-28 23:38","pubTimestamp":1787931501,"startTime":"0","endTime":"0","summary":"An update from ISEC Healthcare Ltd ( ($SG:40T) ) is now available. ISEC Healthcare has announced that its joint venture, ISEC (Seremban) Sdn. Bhd.,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/isec-healthcares-seremban-eye-centre-begins-operations-after-securing-license?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/isec-healthcares-seremban-eye-centre-begins-operations-after-securing-license?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","XLV","BK4581","SG","LU0128526141.USD","BK4585","BK4209","LU0029874061.USD","HCSG","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":20,"totalSize":410,"code":"91000000","status":"200"}]}}